WCN26-7838 Improved Kidney Allograft Survival Following Repeated Anti-Rejection Therapy in Patients with Antibody-Mediated Rejection and Persistent Microvascular Inflammation under Active Histological Surveillance

Read full text Summarise with VIRAT
Authors: Erick Yasar Zúñiga-González, Luis Agustín Camacho Murillo, Norma Uribe, Lluvia Aurora Marino Vazquez, Luis Eduardo Morales Buenrostro
Cited by: 0

Summary

No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.

Summarise with VIRAT Free to try with your Science Catalogs account.

Abstract

Antibody-mediated rejection (AMR) remains the leading cause of kidney allograft loss. Persistent inflammation on follow-up biopsies after anti-rejection therapy has been associated with worse outcomes. This study evaluated the impact of performing post-treatment biopsies and applying targeted re-treatment on graft survival.

Fields of Study & Subjects

Renal Transplantation Outcomes and Treatments Transplantation: Methods and Outcomes Organ Donation and Transplantation

Publication details

Journal / source
Kidney International Reports
Volume
11
Issue
4
Pages
105535–105535
Publication date
25 March 2026
Language
EN